---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007716"
form_type: "8-K"
ticker: "CRSP"
cik: "0001674416"
company_name: "CRISPR Therapeutics AG"
filed_at: "2023-03-14T23:59:59+00:00"
generated_at: "2026-06-18T03:26:00.441098+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CRISPR Therapeutics appoints Raju Prasad as CFO, replaces Brendan Smith

## Summary
- Raju Prasad, Ph.D., appointed CFO effective March 14, 2023; previously Partner at William Blair.
- Annual salary $465,000, target bonus 45%, option grant for 100,000 shares, RSU grant for 40,000 shares.
- Brendan Smith resigned as CFO effective March 13, 2023; no disagreement on financial reporting.
- Smith remains employee through March 31, 2023, with continued equity vesting.
- Prasad receives $100,000 one-time payment, forfeitable if terminated for cause before March 14, 2024.

## SEC filing metadata
- accession: 0000950170-23-007716
- form_type: 8-K
- ticker: CRSP
- cik: 0001674416
- company_name: CRISPR Therapeutics AG
- filed_at: 2023-03-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674416/000095017023007716/0000950170-23-007716-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674416/000095017023007716/crsp-20230309.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007716
- JSON: https://secwatch.observer/filing/0000950170-23-007716.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007716.txt

## Key facts
- Executive change
  Raju Prasad was appointed as Chief Financial Officer at CRISPR Therapeutics AG.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On March 13, 2023, CRISPR Therapeutics AG (the “Company”) announced the hiring and appointment of Raju Prasad, Ph.D. as its Chief Financial Officer, effective March 14, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1674416/000095017023007716/0000950170-23-007716-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.